These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2458825)

  • 1. Histologic markers in primary and metastatic tumors of the liver.
    Ganjei P; Nadji M; Albores-Saavedra J; Morales AR
    Cancer; 1988 Nov; 62(9):1994-8. PubMed ID: 2458825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.
    Ferrandez-Izquierdo A; Llombart-Bosch A
    Pathol Res Pract; 1987 Dec; 182(6):783-91. PubMed ID: 2449680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
    Chu PG; Ishizawa S; Wu E; Weiss LM
    Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.
    Brumm C; Schulze C; Charels K; Morohoshi T; Klöppel G
    Histopathology; 1989 May; 14(5):503-13. PubMed ID: 2472345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical evaluation of liver fine-needle aspirations.
    Bedrossian CW; Davila RM; Merenda G
    Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study on hepatic tumors--KM01 stains compared with AFP, CEA, CA19-9 and RAS P21.
    Hanabata M; Ohyanagi H; Saitoh Y; Itoh H
    Kobe J Med Sci; 1991 Apr; 37(2):81-96. PubMed ID: 1717740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin.
    Martín de las Mulas J; Gómez-Villamandos JC; Pérez J; Mozos E; Estrado M; Méndez A
    Res Vet Sci; 1995 Sep; 59(2):124-7. PubMed ID: 8525100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
    Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
    Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
    Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
    Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour markers in diagnosis and management.
    Warnes TW; Smith A
    Baillieres Clin Gastroenterol; 1987 Jan; 1(1):63-89. PubMed ID: 2437983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma.
    Yano H; Kojiro M; Nakashima T
    In Vitro Cell Dev Biol; 1986 Nov; 22(11):637-46. PubMed ID: 2430933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
    Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
    J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
    Tsuji M; Kashihara T; Terada N; Mori H
    Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
    Fucich LF; Cheles MK; Thung SN; Gerber MA; Marrogi AJ
    Arch Pathol Lab Med; 1994 Sep; 118(9):927-30. PubMed ID: 7521638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA.
    Oliveira AM; Erickson LA; Burgart LJ; Lloyd RV
    Am J Surg Pathol; 2000 Feb; 24(2):177-82. PubMed ID: 10680884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of alpha-fetoprotein, carcinoembryonic antigen, and ferritin in formalin-paraffin sections from hepatocellular carcinoma.
    Imoto M; Nishimura D; Fukuda Y; Sugiyama K; Kumada T; Nakano S
    Am J Gastroenterol; 1985 Nov; 80(11):902-6. PubMed ID: 2413756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
    Fu X; Tan L; Liu S; Li H; Chen L; Qin J; Wu M; Wang H
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):514-20. PubMed ID: 15221469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of tumour marker proteins in the diagnosis of primary hepatocellular carcinoma.
    Oon CJ; Yo SL; Chio LF; Chua D; Tan YO
    Ann Acad Med Singap; 1980 Apr; 9(2):228-33. PubMed ID: 6158907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
    Goodman ZD; Ishak KG; Langloss JM; Sesterhenn IA; Rabin L
    Cancer; 1985 Jan; 55(1):124-35. PubMed ID: 2578078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
    Bell H
    Scand J Gastroenterol; 1982 Oct; 17(7):897-903. PubMed ID: 6186010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.